June 29, 2014 | The ReWalk exoskeleton, a device that helps paraplegics walk, announced that its life-changing device was certified by the FDA in the United States. The device, which straps on to the user’s legs and involves the use of crutches to allow those usually confined to wheelchairs to traverse various indoor and outdoor environments, costs about €52,500 ($72,000) in Europe. The US pricing for the device has yet to be revealed. The ReWalk device was created in 2011 by Israeli company Argo Medical Technologies’ founder Dr. Amit Goffer, who himself is a quadriplegic.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli Startup Tests Cancer Treatment With Pharma Giant
February 07, 2023

EU Awards $5M To Greenhouse Solar Panel Project
February 07, 2023

Israel Builds Super-Advanced Children’s Hospital
February 07, 2023

Two Thirds Of Hi-Tech Workers In Israel Are Men, Study Finds
February 06, 2023
Facebook comments